Metabolically stable bradykinin B2 receptor agonists enhance transvascular drug delivery into malignant brain tumors by increasing drug half-life. [electronic resource]
Producer: 20090708Description: 33 p. digitalISSN:- 1479-5876
- Animals
- Antineoplastic Agents -- pharmacology
- Blood Pressure -- drug effects
- Blood-Brain Barrier -- drug effects
- Brain Neoplasms -- blood supply
- Dose-Response Relationship, Drug
- Drug Delivery Systems
- Drug Stability
- Gadolinium DTPA -- blood
- Glioma -- blood supply
- Half-Life
- Infusions, Intravenous
- Muscle, Skeletal -- drug effects
- Rats
- Rats, Inbred F344
- Receptor, Bradykinin B2 -- agonists
- Time Factors
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.